Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Hormone Research|April 30, 2002
Maturity-onset diabetes of the young (MODY): genetic and clinical characteristicsGilberto Velho, Jean-Jacques RobertCurrent Opinion in Nephrology and Hypertension|April 14, 2017
Vasopressin and diabetic nephropathyRonan Roussel, Gilberto Velho, Lise BankirMedecine Sciences : M/S|November 1, 2003
[MODY, a model of genotype/phenotype interactions in type 2 diabetes]Gilberto Velho, Christine Bellanné-Chantelot, José TimsitCurrent Diabetes Reports|March 18, 2006
Genetics of macrovascular complications in diabetesFrédéric Fumeron, André F Reis, Gilberto VelhoCardiovascular Diabetology|May 14, 2021
SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesisLouis Potier, Kamel Mohammedi, Gilberto Velho, et al.Treatments in Endocrinology|January 15, 2005
Diagnosis and management of maturity-onset diabetes of the youngJosé Timsit, Christine Bellanné-Chantelot, Danièle Dubois-Laforgue, et al.Cells|December 23, 2022
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 DiabetesKamel Mohammedi, Michel Marre, Samy Hadjadj, et al.Diabetes Research and Clinical Practice|October 20, 2018
Glucagon revisited: Coordinated actions on the liver and kidneyLise Bankir, Nadine Bouby, Robert C Speth, et al.Molecular Genetics and Metabolism|August 17, 2004
A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetesAndré F Reis, Danièle Dubois-Laforgue, Christine Bellanné-Chantelot, et al.Biochimie|January 24, 2004
Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetesEric Duplus, Chantal Benelli, André F Reis, et al.Pageof 9